Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.55
Bid: 0.50
Ask: 0.60
Change: -0.02 (-3.51%)
Spread: 0.10 (20.00%)
Open: 0.575
High: 0.575
Low: 0.525
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement on Convertible Loan Note Refinancing

27 Nov 2023 07:00

RNS Number : 6740U
Bushveld Minerals Limited
27 November 2023
 

Market Abuse Regulation ("MAR") Disclosure

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

Bushveld Minerals Limited

("Bushveld" or the "Company")

 

Agreement on Convertible Loan Note Refinancing

 

27 November 2023

 

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that it has entered into a conditional agreement to refinance its existing convertible loan notes with Orion Mine Finance ("Orion"), following the Term Sheet agreed in May this year.

 

Highlights:

 

§ Today's conditional agreement extends the maturity date for Bushveld's existing convertible loan notes to 31 January 2024 (from 21 December 2023) and refinances the convertible debt obligations of c.US$46.9 million (including accrued interest) as follows:

· Conversion of 10% of the outstanding balance (including interest) of the convertible debt obligations ("CLN Balance"), expected to be c.US$4.7 million, as at the effective date[1] into shares at 3.00p per share.

· A new convertible loan note of c.US$14.1 million representing 30% of the CLN Balance maturing in June 2028.

· A term loan of c.US$28.1 million representing 60% of the CLN Balance.

· Supplemental royalty at not more than 0.264% of Bushveld's gross revenues and reducing by 80% at the term loan maturity.

 

§ New structure better aligns repayment with expected internal cash generation projections.

 

§ The refinancing is conditional upon (inter alia):

· Entry into the finance and security documents, which are progressing accordingly.

· Bushveld shareholder approval.

· Raising of at least US$12.0 million via the issue of new ordinary shares in the Company to third party and existing investors (which would be satisfied by the proposed equity investment by Southern Point Resources - Fund 1 SA L.P., represented by its general partner SPR GP1 Proprietary Limited).

· Consent by the Financial Surveillance Department of the South African Reserve Bank.

· Completion of the Share Exchange transaction between the Company and the minority shareholders in Bushveld Vametco Holdings Pty Ltd, by which the Company will become the 100% shareholder in Bushveld Vametco Holdings Pty Ltd, as announced on 30 October 2023.

 

§ All outstanding conditions are expected to be satisfied in due course, and the transaction is expected to complete before the 31 January 2024 deadline agreed by all parties.

 

 

 

Craig Coltman, CEO of Bushveld Minerals commented:

"I am pleased to announce today's agreement with Orion, which has supported the Company since it's initial investment three years ago. Since first announcing the terms of the proposed restructuring earlier this year, there has been an imperative to enter into a binding agreement with Orion, and whilst the refinancing remains conditional upon certain items, including Bushveld shareholders' approval, it provides certainty as we move forward with the other elements of our financial package.

The restructuring is a key part of our strategy to restore value in the Company, along with ensuring Bushveld delivers its operational targets, simplifies its corporate structure and refines its investment proposition."

 

 

Key Terms of the Proposed Refinancing

§ 10% of the CLN Balance (c. US$4.7 million) to be capitalised into a subscription for shares in Bushveld at 3.00p per share, a 48% premium to the 20-day weighted average share price (as at 24 November 2023).

 

§ 30% of the CLN Balance (c.US$14.1 million) to remain as a convertible loan note with the following revised terms ("New CLN"):

· Interest: 12%

· Conversion price: 3.99p

· Maturity Date: 30 June 2028

· Bushveld shall have a one-time right to redeem 50% (in whole and not in part) of the New CLN in June 2026, subject to the right of Orion to elect for conversion of the same for a 30-day period.

 

§ 60% of the CLN Balance (c.US$28.1 million) will be converted into a secured term loan ("Term Loan") on the following terms:

· Interest: 6.0% ("Margin") plus the greater of (i) 3-month Secured Overnight Financing Rate ("SOFR") and (ii) 3.0% per annum.

· Interest payable quarterly in arrears in cash starting from the last business day of the quarter in which the closing of the transaction occurs and on the last business day of each quarter thereafter. In the event that the Company has insufficient cash available to pay interest on its due date, the interest due on that date shall continue to accrue. In the event of default, the Margin will be increased by 3%.

 Principal repayments structured to

a. 25% of the facility amount (c. US$7.0 million) to be repaid by 30 June 2024

b. 30% of the facility amount (c. US$8.4 million) to be repaid by 30 June 2025

c. 45% of the facility amount (c. US$12.6 million) to be repaid by 30 June 2026

 

· The facility may be prepaid in whole or in part at any time. Prepayment is subject to the following early redemption fee schedule based on the outstanding balance at the time of prepayment.

Prior to 30 June 2024: 4%

After 30 June 2024 until 30 June 2025: 3%

After 30 June 2025 until 30 June 2026: 2% 

 

§ Supplemental royalty, on the same terms as the existing Production Financing Agreement during the tenure of the Term Loan, except for the following:

· Royalty repayment rate of 0.264% with a realised price per kgV of less than US$47/kgV.

· Royalty repayment rate of 0.216% with a realised price per kgV of greater than US$47/kgV.

· The later of 30 June 2027 and when the Term Loan has been fully repaid, the repayment rate will reduce by 80% and shall be payable for the life of the Vametco operation.

 

 

 

ENDS

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

 

 

 


[1] The date on which all conditions referred to below are satisfied.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDBBDBDDDDGXL
Date   Source Headline
26th Jan 20227:00 amRNSQ4 and Full Year 2021 Operational Update
19th Jan 20227:00 amRNSRevised Arrangement on Mustang's VRFB-H Investment
17th Jan 20222:41 pmRNSFurther Update on VRFB-H Investment by Mustang
11th Jan 20223:27 pmRNSUpdate on VRFB Holdings Limited Investment
30th Dec 20217:00 amRNSTermination of Corporate Broker Services
16th Nov 20214:58 pmRNSHolding(s) in Company
8th Nov 20212:12 pmRNSRepayment of Duferco loan note and issue of shares
27th Oct 20217:00 amRNSRepayment of Duferco convertible loan note
21st Oct 20217:00 amRNSQ3 and 9 months 2021 Operational Update
27th Sep 20217:00 amRNSInterim Results for Six Months ended 30 June 2021
20th Aug 20214:24 pmRNSPDMR Dealing to Satisfy Tax Obligations
11th Aug 20213:59 pmRNSHolding(s) in Company
6th Aug 20212:43 pmRNSIssue of Equity PDMR Dealing & Total Voting Rights
5th Aug 20215:00 pmRNSAGM Results
29th Jul 202111:41 amRNSAnnual General Meeting Webcast - Correction
28th Jul 202111:36 amRNSAnnual General Meeting Webcast
21st Jul 20217:00 amRNSQ2 2021 and H1 2021 Operational Update
14th Jul 20217:20 amRNSAnnouncement on Litigation
13th Jul 20217:00 amRNSPosting of accounts and notice of general meeting
7th Jul 202112:05 pmRNSInvestor Presentation
30th Jun 20217:38 amRNSFinal Results for the Year Ended 31 December 2020
14th May 20214:30 pmRNSHolding(s) in Company
14th May 20214:29 pmRNSHolding(s) in Company
14th May 20217:00 amRNSQ1 2021 Operational Update
27th Apr 20217:00 amRNSUpdate on Enerox GmbH Investment
21st Apr 20214:18 pmRNSUnprotected Industrial Action Resolved
19th Apr 20218:42 amRNSUnprotected Industrial Action
1st Apr 20219:04 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSFollow-on investment in Enerox GmbH
30th Mar 20214:25 pmRNSHolding(s) in Company
25th Mar 20211:27 pmRNSHolding(s) in Company
26th Feb 20211:37 pmRNSTotal Voting Rights
25th Feb 20215:56 pmRNSDirector/PDMR Shareholding
19th Feb 20215:43 pmRNSDirector/PDMR Shareholding
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20216:04 pmRNSDirector/PDMR Shareholding
16th Feb 20215:28 pmRNSDirector/PDMR Shareholding
12th Feb 20213:28 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSQ4 and FY2020 Operational Update - Correction
4th Feb 20217:01 amRNSQ4 and Full Year 2020 Operational Update
4th Feb 20217:00 amRNSVametco Mineral Resources and Reserves update
2nd Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSEquity Issue, PDMR Dealing & Total Voting Rights
11th Jan 202111:12 amRNSHolding(s) in Company
11th Jan 202110:46 amRNSDeath of Ms Dolly Mokgatle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.